Britain said it was working with partners on the potential for "human challenge" clinical trials for a Covid-19 vaccine, where volunteers are deliberately infected with the virus to test the effectiveness of vaccine candidates, confirming an FT report.
"We are working with partners to understand how we might collaborate on the potential development of a Covid-19 vaccine through human challenge studies," a government spokeswoman said.
"These discussions are part of our work to research ways of treating, limiting and hopefully preventing the virus so we can end the pandemic sooner."
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU